| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
|
Boulbes, Delphine R.
|
|
2015
|
151 |
3 |
p. 501-513
|
artikel
|
| 2 |
Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial)
|
Ruddy, Kathryn J.
|
|
2015
|
151 |
3 |
p. 589-596
|
artikel
|
| 3 |
Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survival
|
Lu, Lingeng
|
|
2015
|
151 |
3 |
p. 491-500
|
artikel
|
| 4 |
Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing
|
Wu, Yong
|
|
2015
|
151 |
3 |
p. 529-539
|
artikel
|
| 5 |
Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer
|
Liu, Rong
|
|
2015
|
151 |
3 |
p. 607-618
|
artikel
|
| 6 |
Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients
|
Hollen, Patricia J.
|
|
2015
|
151 |
3 |
p. 679-686
|
artikel
|
| 7 |
Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study
|
Karasneh, Reema A.
|
|
2015
|
151 |
3 |
p. 661-669
|
artikel
|
| 8 |
Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis
|
Luengo-Gil, Ginés
|
|
2015
|
151 |
3 |
p. 577-587
|
artikel
|
| 9 |
Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis
|
Wong, William W. L.
|
|
2015
|
151 |
3 |
p. 639-652
|
artikel
|
| 10 |
Identification of clinically relevant alterations in phyllodes tumor of the breast by amplicon-based next-generation sequencing
|
Tsang, Julia Y. S.
|
|
2015
|
151 |
3 |
p. 717-719
|
artikel
|
| 11 |
Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer
|
Beg, Shaham
|
|
2015
|
151 |
3 |
p. 541-553
|
artikel
|
| 12 |
Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer
|
Scholz, Christoph
|
|
2015
|
151 |
3 |
p. 569-576
|
artikel
|
| 13 |
Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study
|
Gil-Gil, Miguel J.
|
|
2015
|
151 |
3 |
p. 597-606
|
artikel
|
| 14 |
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)
|
Kaklamani, Virginia G.
|
|
2015
|
151 |
3 |
p. 629-638
|
artikel
|
| 15 |
Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes
|
Lee, Hee Jin
|
|
2015
|
151 |
3 |
p. 619-627
|
artikel
|
| 16 |
Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer
|
Zhang, Hua
|
|
2015
|
151 |
3 |
p. 555-568
|
artikel
|
| 17 |
Racial and ethnic differences in risk of second primary cancers among breast cancer survivors
|
Calip, Gregory S.
|
|
2015
|
151 |
3 |
p. 687-696
|
artikel
|
| 18 |
Racial differences in outcomes for patients with metastatic breast cancer by disease subtype
|
Vaz-Luis, Ines
|
|
2015
|
151 |
3 |
p. 697-707
|
artikel
|
| 19 |
Relevance of βGal–βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients
|
Milde-Langosch, Karin
|
|
2015
|
151 |
3 |
p. 515-528
|
artikel
|
| 20 |
Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry
|
Menes, Tehillah S.
|
|
2015
|
151 |
3 |
p. 653-660
|
artikel
|
| 21 |
Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer
|
Soysal, Savas D.
|
|
2015
|
151 |
3 |
p. 709-715
|
artikel
|
| 22 |
TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li–Fraumeni family
|
Kappel, Sonja
|
|
2015
|
151 |
3 |
p. 671-678
|
artikel
|
| 23 |
VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis
|
Santos, Lucas Vieira dos
|
|
2015
|
151 |
3 |
p. 481-489
|
artikel
|
Tijdschrift beschrijving